Literature DB >> 1315508

Varicella zoster virus DNA in throat swabs of vaccinees.

T Ozaki1, H Miwata, Y Asano, J Namazue, K Yamanishi.   

Abstract

Ninety throat swabs from 30 healthy children who received varicella vaccine were tested for varicella zoster virus DNA by the polymerase chain reaction. Seroconversion was observed in 27 of 30 (90%) vaccinees. The positive rates were 7.4% (2/27) at one week and 0% (0/27) at four weeks after vaccination. These rates were considerably lower than those in normal children with varicella.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1315508      PMCID： PMC1793660          DOI： 10.1136/adc.67.3.328

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  4 in total

1.  Detection of antibody to Varicella-Zoster virus by immune adherence hemagglutination.

Authors:  A A Gershon; Z G Kalter; S Steinberg; W J Kuhns
Journal:  Proc Soc Exp Biol Med       Date:  1976-04

2.  Use of a live varicella vaccine to prevent the spread of varicella in handicapped or immunosuppressed children including MCLS (muco-cutaneous lymphnode syndrome) patients in hospitals.

Authors:  K Ueda; I Yamada; M Goto; T Nanri; H Fukuda; M Katsuta; T Otsuka; M Takahashi
Journal:  Biken J       Date:  1977-12

3.  Letter: Contact infection from live varicella vaccine recipients.

Authors:  Y Asano; T Yazaki; S Ito; S Isomura; M Takahashi
Journal:  Lancet       Date:  1976-05-01       Impact factor: 79.321

4.  Detection of varicella-zoster virus (VZV) DNA in clinical samples from patients with VZV by the polymerase chain reaction.

Authors:  S Kido; T Ozaki; H Asada; K Higashi; K Kondo; Y Hayakawa; T Morishima; M Takahashi; K Yamanishi
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.